(Q42797099)

7 November 2017

The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices (English)

1 reference

7 November 2017

Pedro Plans-Rubió

1

1 reference

7 November 2017

1 January 2010

1 reference

American journal of cardiovascular drugs

7 November 2017

1 reference

7 November 2017

10

1 reference

7 November 2017

6

1 reference

7 November 2017

369-382

1 reference

https://scigraph.springernature.com/pub.10.2165/11539150-000000000-00000

7 November 2017

0 references

cites work

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.2165%2F11539150-000000000-00000

Crossref

reference URL

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539150-000000000-00000

Crossref

reference URL

Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11539150-000000000-00000

Crossref

reference URL

10.2165/11539150-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

21090830

Dimensions Publication ID

7 November 2017

0 references

1 reference

PubMed ID

21090830